To ensure our target genes were successfully cloned into the pSB1C3 backbone, we ran the electrophoresis of Taq PCR products to check the sizes of the insert genes.
(Created page with "{{NCTU_Formosa/test}} <html> <head> <meta charset="UTF-8"> <title>Protein Expression</title> <script src="https://ajax.googleapis.com/ajax/libs/jquery/3.2.1/jquery.min....") |
|||
(141 intermediate revisions by 9 users not shown) | |||
Line 23: | Line 23: | ||
padding: 0 !important; | padding: 0 !important; | ||
width: 100%; | width: 100%; | ||
+ | overflow: auto; | ||
} | } | ||
.wrapper{ | .wrapper{ | ||
width: 100%; | width: 100%; | ||
− | overflow: | + | overflow: hidden; |
+ | padding-bottom: 150px; | ||
} | } | ||
.cover{ | .cover{ | ||
width: 100%; | width: 100%; | ||
+ | position: relative; | ||
} | } | ||
+ | .title_title{ | ||
+ | width: 50%; | ||
+ | margin-left: 25%; | ||
+ | padding-top: 100px; | ||
+ | } | ||
.title{ | .title{ | ||
font-size: 7vmin; | font-size: 7vmin; | ||
− | + | padding-top: 40px; | |
− | + | ||
text-align: center; | text-align: center; | ||
} | } | ||
.title_1{ | .title_1{ | ||
− | font-size: | + | font-size: 7vmin; |
width: 75%; | width: 75%; | ||
margin: 50px; | margin: 50px; | ||
− | |||
margin-left: 12.5%; | margin-left: 12.5%; | ||
+ | margin-bottom: 20px; | ||
} | } | ||
Line 65: | Line 72: | ||
.text{ | .text{ | ||
− | font-size: | + | font-size: 3vmin; |
width: 75%; | width: 75%; | ||
position: relative; | position: relative; | ||
Line 87: | Line 94: | ||
table{ | table{ | ||
− | width: | + | width: 45%; |
border: solid 2px #e7eceb; | border: solid 2px #e7eceb; | ||
text-align: left; | text-align: left; | ||
Line 101: | Line 108: | ||
border: solid 1px #e7eceb; | border: solid 1px #e7eceb; | ||
margin: 15px; | margin: 15px; | ||
− | |||
} | } | ||
− | td | + | td{ |
− | padding: 10px; | + | padding: 15px; |
+ | padding-top: 10px; | ||
+ | padding-bottom: 10px; | ||
+ | } | ||
+ | |||
+ | th{ | ||
+ | padding: 15px; | ||
+ | padding-top: 10px; | ||
+ | padding-bottom: 10px; | ||
} | } | ||
Line 117: | Line 131: | ||
thead{ | thead{ | ||
− | background: # | + | background: #142968; |
color: #fefefe; | color: #fefefe; | ||
− | font-size: | + | font-size: 3vmin; |
} | } | ||
tbody{ | tbody{ | ||
− | font-size: | + | font-size: 2.5vmin; |
} | } | ||
Line 139: | Line 153: | ||
} | } | ||
+ | .expression{ | ||
+ | width: 50%; | ||
+ | margin-left: 25%; | ||
+ | margin-top: 50px; | ||
+ | margin-bottom: 10px; | ||
+ | } | ||
+ | .expression1{ | ||
+ | width: 15%; | ||
+ | display: inline-block; | ||
+ | margin-top: 50px; | ||
+ | margin-bottom: 10px; | ||
+ | } | ||
+ | .sec1{ | ||
+ | padding: 0; | ||
+ | padding-bottom: 50px; | ||
+ | padding-top: 50px; | ||
+ | margin: 0; | ||
+ | border: 0; | ||
+ | overflow: hidden; | ||
+ | } | ||
+ | .sec2{ | ||
+ | padding: 0; | ||
+ | margin: 0; | ||
+ | border: 0; | ||
+ | overflow: hidden; | ||
+ | } | ||
+ | |||
+ | .cloning{ | ||
+ | margin-left: 27.5%; | ||
+ | width: 45%; | ||
+ | } | ||
+ | |||
+ | .clone{ | ||
+ | width: 100%; | ||
+ | } | ||
+ | |||
+ | .sds{ | ||
+ | width: 50%; | ||
+ | margin-left: 25%; | ||
+ | } | ||
+ | |||
+ | #sds_3{ | ||
+ | width: 26.8%; | ||
+ | margin-left: 21.6%; | ||
+ | } | ||
+ | |||
+ | .protein{ | ||
+ | position: absolute; | ||
+ | width: 12%; | ||
+ | left: 23.5%; | ||
+ | top: 15.8vw; | ||
+ | transition-duration: 0.4s; | ||
+ | } | ||
+ | |||
+ | .mic{ | ||
+ | position: absolute; | ||
+ | width: 12%; | ||
+ | left: 51.5%; | ||
+ | top: 11.4vw; | ||
+ | transition-duration: 0.4s; | ||
+ | } | ||
+ | |||
+ | .sensor{ | ||
+ | position: absolute; | ||
+ | width: 12%; | ||
+ | left: 82.5%; | ||
+ | top: 16vw; | ||
+ | transition-duration: 0.4s; | ||
+ | } | ||
+ | |||
+ | .protein:hover{ | ||
+ | transform: scale(1.2); | ||
+ | } | ||
+ | |||
+ | .growth:hover{ | ||
+ | transform: scale(1.2); | ||
+ | } | ||
+ | |||
+ | .mic:hover{ | ||
+ | transform: scale(1.2); | ||
+ | } | ||
+ | |||
+ | .sensor:hover{ | ||
+ | transform: scale(1.2); | ||
+ | } | ||
+ | .sds_page{ | ||
+ | width: 60%; | ||
+ | margin-left: 20%; | ||
+ | } | ||
+ | .sds_entb{ | ||
+ | width: 30%; | ||
+ | margin-left: 35%; | ||
+ | margin-bottom: 1vw; | ||
+ | text-align: left; | ||
+ | } | ||
</style> | </style> | ||
Line 179: | Line 288: | ||
<div class="wrapper"> | <div class="wrapper"> | ||
<div class="banner"> | <div class="banner"> | ||
− | <img class="cover" src="https://static.igem.org/mediawiki/2018/ | + | <img class="cover" src="https://static.igem.org/mediawiki/2018/c/c5/T--NCTU_Formosa--wetlab6.png"> |
+ | <a href="https://2018.igem.org/Team:NCTU_Formosa/Wet_Lab/Expression"><img src="https://static.igem.org/mediawiki/2018/6/6e/T--NCTU_Formosa--protein_expression.png" class="protein"></a> | ||
+ | <a href="https://2018.igem.org/Team:NCTU_Formosa/Wet_Lab/Functional_Analysis"><img src="https://static.igem.org/mediawiki/2018/7/70/T--NCTU_Formosa--MIC.png" class="mic"></a> | ||
+ | <a href="https://2018.igem.org/Team:NCTU_Formosa/Wet_Lab/Curcumin_Biosensor"><img src="https://static.igem.org/mediawiki/2018/2/20/T--NCTU_Formosa--biosensor.png" class="sensor"></a> | ||
</div> | </div> | ||
− | <div class="sec1"> | + | <div class="sec1" style="background-color:#fff;"> |
− | <div class=" | + | <img src="https://static.igem.org/mediawiki/2018/a/ad/T--NCTU_Formosa--Expression_design_title.png" class="title_title"> |
+ | <div class="title_1"><p>Cloning</p></div> | ||
+ | <div class="text"> | ||
+ | <p> To ensure our target genes were successfully cloned into the pSB1C3 backbone, we ran the electrophoresis of Taq PCR products to check the sizes of the insert genes.</p> | ||
+ | </div> | ||
+ | <div class="text"> | ||
+ | <p>All of the sequences contained T7 promoter, RBS, bacteriocin, intein and CBD, were shown in Figure 1.</p> | ||
+ | </div> | ||
+ | <img src="https://static.igem.org/mediawiki/2018/a/aa/T--NCTU_Formosa--biobrick.png" class="expression"> | ||
+ | <div class="explanation"> | ||
+ | <svg class="icon" aria-hidden="true" data-prefix="fas" data-icon="arrow-circle-up" class="svg-inline--fa fa-arrow-circle-up fa-w-16" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><path fill="currentColor" d="M8 256C8 119 119 8 256 8s248 111 248 248-111 248-248 248S8 393 8 256zm143.6 28.9l72.4-75.5V392c0 13.3 10.7 24 24 24h16c13.3 0 24-10.7 24-24V209.4l72.4 75.5c9.3 9.7 24.8 9.9 34.3.4l10.9-11c9.4-9.4 9.4-24.6 0-33.9L273 107.7c-9.4-9.4-24.6-9.4-33.9 0L106.3 240.4c-9.4 9.4-9.4 24.6 0 33.9l10.9 11c9.6 9.5 25.1 9.3 34.4-.4z"></path></svg> | ||
+ | Figure 1: Our BioBrick design | ||
+ | </div> | ||
+ | <div class="text"> | ||
+ | <p> After amplification with PCR, all the PCR products' lengths are around 1200 b.p. The exact lengths are listed in Table 1.</p> | ||
+ | </div> | ||
<div class="table"> | <div class="table"> | ||
<table> | <table> | ||
Line 188: | Line 315: | ||
<p class="explanation"> | <p class="explanation"> | ||
<svg class="icon" aria-hidden="true" data-prefix="fas" data-icon="arrow-circle-down" class="svg-inline--fa fa-arrow-circle-down fa-w-16" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><path fill="currentColor" d="M504 256c0 137-111 248-248 248S8 393 8 256 119 8 256 8s248 111 248 248zm-143.6-28.9L288 302.6V120c0-13.3-10.7-24-24-24h-16c-13.3 0-24 10.7-24 24v182.6l-72.4-75.5c-9.3-9.7-24.8-9.9-34.3-.4l-10.9 11c-9.4 9.4-9.4 24.6 0 33.9L239 404.3c9.4 9.4 24.6 9.4 33.9 0l132.7-132.7c9.4-9.4 9.4-24.6 0-33.9l-10.9-11c-9.5-9.5-25-9.3-34.3.4z"></path></svg> | <svg class="icon" aria-hidden="true" data-prefix="fas" data-icon="arrow-circle-down" class="svg-inline--fa fa-arrow-circle-down fa-w-16" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><path fill="currentColor" d="M504 256c0 137-111 248-248 248S8 393 8 256 119 8 256 8s248 111 248 248zm-143.6-28.9L288 302.6V120c0-13.3-10.7-24-24-24h-16c-13.3 0-24 10.7-24 24v182.6l-72.4-75.5c-9.3-9.7-24.8-9.9-34.3-.4l-10.9 11c-9.4 9.4-9.4 24.6 0 33.9L239 404.3c9.4 9.4 24.6 9.4 33.9 0l132.7-132.7c9.4-9.4 9.4-24.6 0-33.9l-10.9-11c-9.5-9.5-25-9.3-34.3.4z"></path></svg> | ||
− | Table 1: The | + | Table 1: The DNA length of each BioBrick |
</p> | </p> | ||
</caption> | </caption> | ||
Line 194: | Line 321: | ||
<tr> | <tr> | ||
<th><p>Bacteriocin</p></th> | <th><p>Bacteriocin</p></th> | ||
− | <th><p> | + | <th style="text-align: center;"><p>Length</p></th> |
+ | <th style="text-align: center;"><p>Length of PCR product</p></th> | ||
</tr> | </tr> | ||
</thead> | </thead> | ||
<tbody> | <tbody> | ||
<tr> | <tr> | ||
− | <td> | + | <td><p>Leucocyclicin Q</p></td> |
− | <td> | + | <td style="text-align: center;"><p>186 b.p.</p></td> |
+ | <td style="text-align: center;"><p>1230 b.p.</p></td> | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
− | <td>Enterocin | + | <td><p>Enterocin B</p></td> |
− | <td> | + | <td style="text-align: center;"><p>210 b.p.</p></td> |
+ | <td style="text-align: center;"><p>1254 b.p.</p></td> | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
− | <td>Enterocin | + | <td><p>Enterocin 96</p></td> |
− | <td> | + | <td style="text-align: center;"><p>219 b.p.</p></td> |
+ | <td style="text-align: center;"><p>1263 b.p.</p></td> | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
− | <td> | + | <td><p>Lacticin Z</p></td> |
− | <td> | + | <td style="text-align: center;"><p>153 b.p.</p></td> |
+ | <td style="text-align: center;"><p>1197 b.p.</p></td> | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
− | <td>Bovicin HJ50</td> | + | <td><p>Bovicin HJ50</p></td> |
− | <td> | + | <td style="text-align: center;"><p>171 b.p.</p></td> |
+ | <td style="text-align: center;"><p>1215 b.p.</p></td> | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
− | <td>Durancin</td> | + | <td><p>Durancin TW-49M</p></td> |
− | <td> | + | <td style="text-align: center;"><p>213 b.p.</p></td> |
+ | <td style="text-align: center;"><p>1257 b.p.</p></td> | ||
</tr> | </tr> | ||
+ | </tbody> | ||
+ | </table> | ||
+ | </div> | ||
+ | <div class="text"> | ||
+ | <p> The figure 2 is electrophoresis results of the PCR products with marker on the left side and target gene on the right side. The lengths are labeled beside each band.</p> | ||
+ | </div> | ||
+ | <div class="cloning"> | ||
+ | <img src="https://static.igem.org/mediawiki/2018/2/2b/T--NCTU_Formosa--exp_clone.png" class="clone"> | ||
+ | </div> | ||
+ | <div class="explanation" style="width: 80%; margin-left: 10%; text-align: justify;"><p> | ||
+ | <svg class="icon" aria-hidden="true" data-prefix="fas" data-icon="arrow-circle-up" class="svg-inline--fa fa-arrow-circle-up fa-w-16" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><path fill="currentColor" d="M8 256C8 119 119 8 256 8s248 111 248 248-111 248-248 248S8 393 8 256zm143.6 28.9l72.4-75.5V392c0 13.3 10.7 24 24 24h16c13.3 0 24-10.7 24-24V209.4l72.4 75.5c9.3 9.7 24.8 9.9 34.3.4l10.9-11c9.4-9.4 9.4-24.6 0-33.9L273 107.7c-9.4-9.4-24.6-9.4-33.9 0L106.3 240.4c-9.4 9.4-9.4 24.6 0 33.9l10.9 11c9.6 9.5 25.1 9.3 34.4-.4z"></path></svg> | ||
+ | Figure 2: Agarose gel electrophoretic patterns of Taq PCR products of six bacteriocin genes containing T7 promoter, RBS, gene segments of intein and CBD: (A) Leucocyclicin Q (BBa_K2599014, 1230 b.p.) (B) Enterocin B (BBa_K2599011, 1254 b.p.) (C) Bovicin HJ50 (BBa_K2599009, 1215 b.p.) (D) Lacticin Z (BBa_K2599013, 1197 b.p.) (E) Enterocin 96 (BBa_K2599012, 1263 b.p.) (F) Durancin TW-49M (BBa_K2599015, 1257 b.p.) | ||
+ | </p></div> | ||
+ | </div> | ||
+ | <div class="sec2" style="background-color:#ffffff;"> | ||
+ | <div class="title_1"><p>Protein Expression</p></div> | ||
+ | <div class="text"> | ||
+ | <p> After the expression from <i>E. coli</i> BL21 Rosetta-gami, we had to check whether the proteins were successfully expressed. We broke <i>E. coli</i> with sonication and ran SDS-PAGE to check the correct sizes of the target proteins. The mass of each protein is presented in Table 2.</p> | ||
+ | </div> | ||
+ | <div class="table"> | ||
+ | <table> | ||
+ | <caption> | ||
+ | <p class="explanation"> | ||
+ | <svg class="icon" aria-hidden="true" data-prefix="fas" data-icon="arrow-circle-down" class="svg-inline--fa fa-arrow-circle-down fa-w-16" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><path fill="currentColor" d="M504 256c0 137-111 248-248 248S8 393 8 256 119 8 256 8s248 111 248 248zm-143.6-28.9L288 302.6V120c0-13.3-10.7-24-24-24h-16c-13.3 0-24 10.7-24 24v182.6l-72.4-75.5c-9.3-9.7-24.8-9.9-34.3-.4l-10.9 11c-9.4 9.4-9.4 24.6 0 33.9L239 404.3c9.4 9.4 24.6 9.4 33.9 0l132.7-132.7c9.4-9.4 9.4-24.6 0-33.9l-10.9-11c-9.5-9.5-25-9.3-34.3.4z"></path></svg> | ||
+ | Table 2. Mass of peptides with intein(kDa). | ||
+ | </p> | ||
+ | </caption> | ||
+ | <thead> | ||
<tr> | <tr> | ||
− | < | + | <th><p>Bacteriocin</p></th> |
− | < | + | <th><p style="white-space: nowrap;">Mass (kDa)</p></th> |
+ | <th><p style="white-space: nowrap;">Mass of peptides with intein</p></th> | ||
</tr> | </tr> | ||
+ | </thead> | ||
+ | <tbody> | ||
<tr> | <tr> | ||
− | <td>Lacticin Z</td> | + | <td><p style="white-space: nowrap;">Leucocyclicin Q</p></td> |
− | <td>5.9</td> | + | <td style="text-align: center;"><p>6.4</p></td> |
+ | <td style="text-align: center;"><p>34.4</p></td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <td><p>Enterocin B</p></td> | ||
+ | <td style="text-align: center;"><p>7.5</p></td> | ||
+ | <td style="text-align: center;"><p>35.5</p></td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <td><p>Bovicin HJ50</p></td> | ||
+ | <td style="text-align: center;"><p>6.25</p></td> | ||
+ | <td style="text-align: center;"><p>34.25</p></td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <td><p>Enterocin 96</p></td> | ||
+ | <td style="text-align: center;"><p>7.9</p></td> | ||
+ | <td style="text-align: center;"><p>35.9</p></td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <td><p>Lacticin Z</p></td> | ||
+ | <td style="text-align: center;"><p>5.9</p></td> | ||
+ | <td style="text-align: center;"><p>33.9</p></td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <td><p style="white-space: nowrap;">Durancin TW-49M</p></td> | ||
+ | <td style="text-align: center;"><p>7.3</p></td> | ||
+ | <td style="text-align: center;"><p>35.3</p></td> | ||
</tr> | </tr> | ||
</tbody> | </tbody> | ||
Line 235: | Line 426: | ||
<div class="text"> | <div class="text"> | ||
<p> | <p> | ||
− | + | The gel of SDS-PAGE results were shown below. The mass of intein-CBD tag is 28 kDa. Therefore, all the results showed the initial mass of each bacteriocin plus the mass of intein-CBD tag. From SDS-PAGE results, we could confirm the production of target peptides. | |
</p> | </p> | ||
</div> | </div> | ||
− | <img src="https://static.igem.org/mediawiki/2018/ | + | <img src="https://static.igem.org/mediawiki/2018/f/f2/T--NCTU_Formosa--exp_SDS.png" class="sds_page"> |
− | <img src="https://static.igem.org/mediawiki/2018/ | + | <div class="explanation" style="width: 80%; margin-left: 10%; text-align: justify;"><p> |
+ | <svg class="icon" aria-hidden="true" data-prefix="fas" data-icon="arrow-circle-up" class="svg-inline--fa fa-arrow-circle-up fa-w-16" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><path fill="currentColor" d="M8 256C8 119 119 8 256 8s248 111 248 248-111 248-248 248S8 393 8 256zm143.6 28.9l72.4-75.5V392c0 13.3 10.7 24 24 24h16c13.3 0 24-10.7 24-24V209.4l72.4 75.5c9.3 9.7 24.8 9.9 34.3.4l10.9-11c9.4-9.4 9.4-24.6 0-33.9L273 107.7c-9.4-9.4-24.6-9.4-33.9 0L106.3 240.4c-9.4 9.4-9.4 24.6 0 33.9l10.9 11c9.6 9.5 25.1 9.3 34.4-.4z"></path></svg> | ||
+ | Figure 3: SDS-PAGE analysis of bacteriocin samples. M: Protein Ladder 5–245 kDa, C: Negative control (only intein+CBD, 28 kDa),<br> | ||
+ | E<sub>A</sub>: Leucocyclicin Q + intein + CBD (BBa_K2599014, 34.4 kDa) E<sub>B</sub>: Enterocin B + intein + CBD (BBa_K2599011, 35.5 kDa) E<sub>C</sub>: Bovicin HJ50 + intein + CBD (BBa_K2599009, 34.25 kDa) E<sub>D</sub>: Enterocin 96 + intein + CBD (BBa_K2599012, 35.9 kDa) E<sub>E</sub>: Lacticin Z + intein + CBD (BBa_K2599013, 33.9 kDa) E<sub>F</sub>: Durancin TW-49M + intein + CBD(BBa_K2599015, 35.3 kDa) | ||
+ | </p> | ||
+ | </div> | ||
+ | <div class="sec2" style="background-color:#ffffff;"> | ||
+ | <div class="title_1"><p>Protein Purification</p></div> | ||
+ | <div class="text"> | ||
+ | <p> Finally, we added 1,4-dithiothreitol(DTT) to purify bacteriocins from intein-CBD tag(28 kDa). The result is shown as below. We used Enterocin B as representative. The result showed that we could successfully purify bacteriocin.</p> | ||
+ | </div> | ||
+ | <img src="https://static.igem.org/mediawiki/2018/6/6f/T--NCTU_Formosa--entb11.png" class="sds_entb"> | ||
<div class="explanation"> | <div class="explanation"> | ||
<svg class="icon" aria-hidden="true" data-prefix="fas" data-icon="arrow-circle-up" class="svg-inline--fa fa-arrow-circle-up fa-w-16" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><path fill="currentColor" d="M8 256C8 119 119 8 256 8s248 111 248 248-111 248-248 248S8 393 8 256zm143.6 28.9l72.4-75.5V392c0 13.3 10.7 24 24 24h16c13.3 0 24-10.7 24-24V209.4l72.4 75.5c9.3 9.7 24.8 9.9 34.3.4l10.9-11c9.4-9.4 9.4-24.6 0-33.9L273 107.7c-9.4-9.4-24.6-9.4-33.9 0L106.3 240.4c-9.4 9.4-9.4 24.6 0 33.9l10.9 11c9.6 9.5 25.1 9.3 34.4-.4z"></path></svg> | <svg class="icon" aria-hidden="true" data-prefix="fas" data-icon="arrow-circle-up" class="svg-inline--fa fa-arrow-circle-up fa-w-16" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><path fill="currentColor" d="M8 256C8 119 119 8 256 8s248 111 248 248-111 248-248 248S8 393 8 256zm143.6 28.9l72.4-75.5V392c0 13.3 10.7 24 24 24h16c13.3 0 24-10.7 24-24V209.4l72.4 75.5c9.3 9.7 24.8 9.9 34.3.4l10.9-11c9.4-9.4 9.4-24.6 0-33.9L273 107.7c-9.4-9.4-24.6-9.4-33.9 0L106.3 240.4c-9.4 9.4-9.4 24.6 0 33.9l10.9 11c9.6 9.5 25.1 9.3 34.4-.4z"></path></svg> | ||
− | Figure : | + | Figure 4: The purification of Enterocin B.<br> |
+ | <p>M: Protein Ladder 5–245 kDa;<br> | ||
+ | C: Negative control. Enterocin B without purification(35.5 kDa);<br> | ||
+ | E: Experimental group. The purified Enterocin B(7.5 kDa).</p> | ||
</div> | </div> | ||
</div> | </div> | ||
Line 248: | Line 453: | ||
<!-----------------------------------------------------------------------------> | <!-----------------------------------------------------------------------------> | ||
− | |||
− | |||
</div> | </div> | ||
+ | </div> | ||
</body> | </body> | ||
</html> | </html> | ||
+ | {{NCTU_Formosa/Top_button}} | ||
{{NCTU_Formosa/Footer}} | {{NCTU_Formosa/Footer}} |
Latest revision as of 15:20, 7 December 2018
Cloning
All of the sequences contained T7 promoter, RBS, bacteriocin, intein and CBD, were shown in Figure 1.
After amplification with PCR, all the PCR products' lengths are around 1200 b.p. The exact lengths are listed in Table 1.
Bacteriocin |
Length |
Length of PCR product |
---|---|---|
Leucocyclicin Q |
186 b.p. |
1230 b.p. |
Enterocin B |
210 b.p. |
1254 b.p. |
Enterocin 96 |
219 b.p. |
1263 b.p. |
Lacticin Z |
153 b.p. |
1197 b.p. |
Bovicin HJ50 |
171 b.p. |
1215 b.p. |
Durancin TW-49M |
213 b.p. |
1257 b.p. |
The figure 2 is electrophoresis results of the PCR products with marker on the left side and target gene on the right side. The lengths are labeled beside each band.
Figure 2: Agarose gel electrophoretic patterns of Taq PCR products of six bacteriocin genes containing T7 promoter, RBS, gene segments of intein and CBD: (A) Leucocyclicin Q (BBa_K2599014, 1230 b.p.) (B) Enterocin B (BBa_K2599011, 1254 b.p.) (C) Bovicin HJ50 (BBa_K2599009, 1215 b.p.) (D) Lacticin Z (BBa_K2599013, 1197 b.p.) (E) Enterocin 96 (BBa_K2599012, 1263 b.p.) (F) Durancin TW-49M (BBa_K2599015, 1257 b.p.)
Protein Expression
After the expression from E. coli BL21 Rosetta-gami, we had to check whether the proteins were successfully expressed. We broke E. coli with sonication and ran SDS-PAGE to check the correct sizes of the target proteins. The mass of each protein is presented in Table 2.
Bacteriocin |
Mass (kDa) |
Mass of peptides with intein |
---|---|---|
Leucocyclicin Q |
6.4 |
34.4 |
Enterocin B |
7.5 |
35.5 |
Bovicin HJ50 |
6.25 |
34.25 |
Enterocin 96 |
7.9 |
35.9 |
Lacticin Z |
5.9 |
33.9 |
Durancin TW-49M |
7.3 |
35.3 |
The gel of SDS-PAGE results were shown below. The mass of intein-CBD tag is 28 kDa. Therefore, all the results showed the initial mass of each bacteriocin plus the mass of intein-CBD tag. From SDS-PAGE results, we could confirm the production of target peptides.
Figure 3: SDS-PAGE analysis of bacteriocin samples. M: Protein Ladder 5–245 kDa, C: Negative control (only intein+CBD, 28 kDa),
EA: Leucocyclicin Q + intein + CBD (BBa_K2599014, 34.4 kDa) EB: Enterocin B + intein + CBD (BBa_K2599011, 35.5 kDa) EC: Bovicin HJ50 + intein + CBD (BBa_K2599009, 34.25 kDa) ED: Enterocin 96 + intein + CBD (BBa_K2599012, 35.9 kDa) EE: Lacticin Z + intein + CBD (BBa_K2599013, 33.9 kDa) EF: Durancin TW-49M + intein + CBD(BBa_K2599015, 35.3 kDa)
Protein Purification
Finally, we added 1,4-dithiothreitol(DTT) to purify bacteriocins from intein-CBD tag(28 kDa). The result is shown as below. We used Enterocin B as representative. The result showed that we could successfully purify bacteriocin.
M: Protein Ladder 5–245 kDa;
C: Negative control. Enterocin B without purification(35.5 kDa);
E: Experimental group. The purified Enterocin B(7.5 kDa).